Insider · CIK 0001822014
Ashley Cordova
Files at NVCR (NovoCure Ltd). First filing Mar 3, 2025, latest Sep 8, 2025.
Ashley Cordova files SEC Form 4 as CEO at NVCR (NovoCure Ltd). Since Mar 3, 2025, Ashley Cordova has reported 1 open-market buy worth $997k and 2 open-market sells worth $304k, the latest filed on Sep 8, 2025.
A track record needs three past buys with six months of prices behind them; Ashley Cordova has 0, so none is measured yet.
The newest scored trade: bought $997k of NVCR on Sep 5, 2025, filed Sep 8, 2025, scored 64 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCR: NovoCure Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | NVCRbuy NovoCure Ltd | $997k 81,550 shares | +23% | +13% from low-63% from high | |
| 31Weak | NVCRsell NovoCure Ltd | $38k 2,053 shares | -1% | - | |
| 38Weak | NVCRsell NovoCure Ltd | $266k 13,494 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2025 | NVCR NovoCure Limited | 2,053 0.00% of outstanding | $38k | Mar 3, 2025 | $266k |
| Feb 28, 2025 | NVCR NovoCure Limited | 2,341 0.00% of outstanding | $43k | Feb 28, 2025 | $223k |
| Feb 27, 2025 | NVCR NovoCure Limited | 11,153 0.01% of outstanding | $223k | Feb 27, 2025 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | NVCR NovoCure Ltd | FTax withholding Ordinary Shares | -17,638 | $13.30 | $235k | 422,570 | Mar 5, 2026 |
| Feb 27, 2026 | NVCR NovoCure Ltd | FTax withholding Ordinary Shares | -11,541 | $13.75 | $159k | 426,028 | Mar 3, 2026 |
| Feb 28, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +23,818 | $0.00 | $0 | 449,846 | Mar 3, 2026 |
| Mar 2, 2026 | NVCR NovoCure Ltd | FTax withholding Ordinary Shares | -2,410 | $13.67 | $33k | 447,436 | Mar 3, 2026 |
| Mar 2, 2026 | NVCR NovoCure Ltd | FTax withholding Ordinary Shares | -7,228 | $13.67 | $99k | 440,208 | Mar 3, 2026 |
| Sep 5, 2025 | NVCR NovoCure Ltd | POpen-market purchase Ordinary Shares | +81,550 | $12.22 | $997k | 437,569 | Sep 8, 2025 |
| Jun 30, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +833 | $15.13 | $13k | 356,019 | Jul 1, 2025 |
| Mar 4, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +151,181 | $18.19 | $2.7M | 355,186 | Mar 6, 2025 |
| Mar 4, 2025 | NVCR NovoCure Ltd | AGrant or award Stock Options (Right to buy)derivative | +224,123 | $18.19 | $4.1M | 224,123 | Mar 6, 2025 |
| Mar 3, 2025 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -2,053 | $18.54 | $38k | 204,005 | Mar 4, 2025 |
| Feb 27, 2025 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -9,345 | $19.92 | $186k | 210,207 | Mar 3, 2025 |
| Feb 27, 2025 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -1,808 | $20.55 | $37k | 208,399 | Mar 3, 2025 |
| Feb 28, 2025 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -2,341 | $18.28 | $43k | 206,058 | Mar 3, 2025 |
| Dec 31, 2024 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +373 | $14.75 | $5,501 | 219,552 | Jan 3, 2025 |
Questions about Ashley Cordova
Answered from the filings on this page, as of the latest one.
Is Ashley Cordova buying or selling?
Not in the last 12 months. Ashley Cordova's latest open-market trade on SEC Form 4 was bought $997k of NVCR on Sep 5, 2025.
How did Ashley Cordova's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ashley Cordova has 0.
Where does Ashley Cordova file Form 4?
Ashley Cordova has filed Form 4 at NVCR (NovoCure Ltd) as Former Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.